In contrast, mutations in MYBPC3, the most prevalent genetic cause of hypertrophic cardiomyopathy, exhibit considerable clinical heterogeneity, ranging from asymptomatic carriers to patients with advanced heart failure and sudden cardiac death. The gene discussed is MYBPC3; the disease is hypertrophic cardiomyopathy.